Rx Only

Ready for 24-48h Central Dispatch

In Stock

CEFNUS DRY SYRUP Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

SyrupPrescription Required (Schedule Drug)

CEFNUS DRY SYRUP

Name: CEFNUS DRY SYRUP
Brand: Sygnus Biotech

Active Drug Composition

Cefixime Oral Suspension 50mg With WFI

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

CEFNUS DRY SYRUP is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.

Dosage FormOral Liquid Suspension / Syrup

Packaging Presentation100ml / 200ml PET Bottle with Graduated Measuring Cap

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Lower Respiratory Tract Infections

Acute Bacterial Sinusitis

Urinary Tract Infections (UTI)

Skin and Soft Tissue Infections

Community-Acquired Pneumonia

Mechanism of Action (MOA)

Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.

Dosage & Posology

Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup

Dosage FormOral Liquid Suspension / Syrup

Packaging Type100ml / 200ml PET Bottle with Graduated Measuring Cap

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

CEFNUS DRY SYRUP features Cefixime Oral Suspension 50mg With WFI prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of CEFNUS DRY SYRUP

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding CEFNUS DRY SYRUP

What is the therapeutic indication and composition of CEFNUS DRY SYRUP?

CEFNUS DRY SYRUP contains Cefixime Oral Suspension 50mg With WFI indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.

What packaging presentations are available for CEFNUS DRY SYRUP?

CEFNUS DRY SYRUP is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for CEFNUS DRY SYRUP?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for CEFNUS DRY SYRUP along with promotional visual aids, product cards, and marketing support.